
CMS Rejects Select Medicare Drug Plan Bids, Tightens Oversight to Curb Premium Hikes for 2026
WASHINGTON, D.C. — In a rare and assertive regulatory move, the Centers for Medicare & Medicaid Services (CMS) has exercised its statutory authority to reject certain standalone prescription drug plan …
CMS Rejects Select Medicare Drug Plan Bids, Tightens Oversight to Curb Premium Hikes for 2026 Read More